Back to Journals » Biologics: Targets and Therapy » Volume 14

Biologics: Targets and Therapy


Archive: Volume 14, 2020

Glycopeptides as Potential Interventions for COVID-19

Demsie DG, Gebre AK, Yimer EM, Alema NM, Araya EM, Bantie AT, Allene MD, Gebremedhin H, Yehualaw A, Tafere C, Tadese HT, Amare B, Weldekidan E, Gebrie D

Biologics: Targets and Therapy 2020, 14:107-114

Published Date: 13 October 2020

Nucleic Acid Therapy for β-Thalassemia

d'Arqom A

Biologics: Targets and Therapy 2020, 14:95-105

Published Date: 15 September 2020

A Review on Novel Drug Targets and Future Directions for COVID-19 Treatment

Wondmkun YT, Mohammed OA

Biologics: Targets and Therapy 2020, 14:77-82

Published Date: 25 August 2020

An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis

Chimenti MS, D'Antonio A, Conigliaro P, Ferrigno S, Vendola A, Ferraioli M, Triggianese P, Costa L, Caso F, Perricone R

Biologics: Targets and Therapy 2020, 14:53-75

Published Date: 20 August 2020

Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases

Marafini I, Monteleone G

Biologics: Targets and Therapy 2020, 14:47-51

Published Date: 15 June 2020

Galanin Receptors as Drug Target for Novel Antidepressants: Review

Demsie DG, Altaye BM, Weldekidan E, Gebremedhin H, Alema NM, Tefera MM, Bantie AT

Biologics: Targets and Therapy 2020, 14:37-45

Published Date: 21 April 2020

Autophagy Regulates the Stemness of Cervical Cancer Stem Cells [Retraction]

Yang Y, Yu L, Li J, Yuan YH, Wang XL, Yan SR, Li DS, Ding Y

Biologics: Targets and Therapy 2020, 14:35-36

Published Date: 26 March 2020

Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre Study

Cimmino MA, Parodi M, Barbieri F, Bombardieri S, Zampogna G, Iagnocco A, Batticciotto A, Sconfienza LM, Sinigaglia L, De Benedetti F, Atzeni F, Sarzi-Puttini P

Biologics: Targets and Therapy 2020, 14:13-21

Published Date: 11 February 2020

Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease

Al Sulais E, AlAmeel T

Biologics: Targets and Therapy 2020, 14:1-11

Published Date: 10 January 2020